The impact of implemented regulations on biosimilars in Slovakia

ConclusionsOur findings show that proactive strategies and policies should be implemented to increase availability and penetration of biosimilars on the Slovak pharmaceutical market to reduce societal losses that are caused by the lack of biosimilar medicines availability.
Source: Health Policy and Technology - Category: Health Management Source Type: research